Literature DB >> 15917541

Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides.

Inna S Radzishevsky1, Shahar Rotem, Fadia Zaknoon, Leonid Gaidukov, Arie Dagan, Amram Mor.   

Abstract

To investigate the importance of increased hydrophobicity at the amino end of antimicrobial peptides, a dermaseptin derivative was used as a template for a systematic acylation study. Through a gradual increase of the acyl moiety chain length, hydrophobicity was monitored and further modulated by acyl conversion to aminoacyl. The chain lengths of the acyl derivatives correlated with a gradual increase in the peptide's global hydrophobicity and stabilization of its helical structure. The effect on cytolytic properties, however, fluctuated for different cells. Whereas acylation gradually enhanced hemolysis of human red blood cells and antiprotozoan activity against Leishmania major, bacteria displayed a more complex behavior. The gram-positive organism Staphylococcus aureus was most sensitive to intermediate acyl chains, while longer acyls gradually led to a total loss of activity. All acyl derivatives were detrimental to activity against Escherichia coli, namely, but not solely, because of peptide aggregation. Although aminoacyl derivatives behaved essentially similarly to the nonaminated acyls, they displayed reduced hydrophobicity, and consequently, the long-chain acyls enhanced activity against all microorganisms (e.g., by up to 12-fold for the aminolauryl derivative) but were significantly less hemolytic than their acyl counterparts. Acylation also enhanced bactericidal kinetics and peptide resistance to plasma proteases. The similarities and differences upon acylation of MSI-78 and LL37 are presented and discussed. Overall, the data suggest an approach that can be used to enhance the potencies of acylated short antimicrobial peptides by preventing hydrophobic interactions that lead to self-assembly in solution and, thus, to inefficacy against cell wall-containing target cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917541      PMCID: PMC1140510          DOI: 10.1128/AAC.49.6.2412-2420.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  60 in total

Review 1.  Diversity of antimicrobial peptides and their mechanisms of action.

Authors:  R M Epand; H J Vogel
Journal:  Biochim Biophys Acta       Date:  1999-12-15

2.  Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity.

Authors:  R Feder; A Dagan; A Mor
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

3.  Antimicrobial peptides are signaling molecules.

Authors:  Michel Salzet
Journal:  Trends Immunol       Date:  2002-06       Impact factor: 16.687

4.  Dermaseptin, a peptide antibiotic, stimulates microbicidal activities of polymorphonuclear leukocytes.

Authors:  B Ammar; A Périanin; A Mor; G Sarfati; M Tissot; P Nicolas; J P Giroud; M Roch-Arveiller
Journal:  Biochem Biophys Res Commun       Date:  1998-06-29       Impact factor: 3.575

Review 5.  Lantibiotics: biosynthesis and biological activities of uniquely modified peptides from gram-positive bacteria.

Authors:  H G Sahl; G Bierbaum
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

6.  Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives.

Authors:  Irina Kustanovich; Deborah E Shalev; Masha Mikhlin; Leonid Gaidukov; Amram Mor
Journal:  J Biol Chem       Date:  2002-02-14       Impact factor: 5.157

7.  Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae.

Authors:  P J Coote; C D Holyoak; D Bracey; D P Ferdinando; J A Pearce
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Sublethal concentrations of pleurocidin-derived antimicrobial peptides inhibit macromolecular synthesis in Escherichia coli.

Authors:  Aleksander Patrzykat; Carol L Friedrich; Lijuan Zhang; Valentina Mendoza; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

9.  Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture.

Authors:  Leah Efron; Arie Dagan; Leonid Gaidukov; Hagai Ginsburg; Amram Mor
Journal:  J Biol Chem       Date:  2002-04-05       Impact factor: 5.157

10.  Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics.

Authors:  S Charpentier; M Amiche; J Mester; V Vouille; J P Le Caer; P Nicolas; A Delfour
Journal:  J Biol Chem       Date:  1998-06-12       Impact factor: 5.157

View more
  29 in total

Review 1.  Designing antimicrobial peptides: form follows function.

Authors:  Christopher D Fjell; Jan A Hiss; Robert E W Hancock; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2011-12-16       Impact factor: 84.694

2.  Mechanisms mediating bactericidal properties and conditions that enhance the potency of a broad-spectrum oligo-acyl-lysyl.

Authors:  Hadar Sarig; Yair Goldfeder; Shahar Rotem; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Antibacterial properties of dermaseptin S4 derivatives under extreme incubation conditions.

Authors:  Tali Rydlo; Shahar Rotem; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

4.  Underlying mechanism of in vivo and in vitro activity of C-terminal-amidated thanatin against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Zheng Hou; Jun Lu; Chao Fang; Ying Zhou; Hui Bai; Xiaogong Zhang; Xiaoyan Xue; Yingying Chen; Xiaoxing Luo
Journal:  J Infect Dis       Date:  2010-12-09       Impact factor: 5.226

5.  Importance of residue 13 and the C-terminus for the structure and activity of the antimicrobial peptide aurein 2.2.

Authors:  John T J Cheng; John D Hale; Jason Kindrachuk; Håvard Jenssen; Havard Jessen; Melissa Elliott; Robert E W Hancock; Suzana K Straus
Journal:  Biophys J       Date:  2010-11-03       Impact factor: 4.033

6.  Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.

Authors:  Shahar Rotem; Inna Radzishevsky; Amram Mor
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

Review 7.  Short native antimicrobial peptides and engineered ultrashort lipopeptides: similarities and differences in cell specificities and modes of action.

Authors:  Maria Luisa Mangoni; Yechiel Shai
Journal:  Cell Mol Life Sci       Date:  2011-05-15       Impact factor: 9.261

8.  Acyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microflora.

Authors:  Y Porat; K Marynka; A Tam; D Steinberg; A Mor
Journal:  Antimicrob Agents Chemother       Date:  2006-10-16       Impact factor: 5.191

9.  Bacterial capture by peptide-mimetic oligoacyllysine surfaces.

Authors:  Shahar Rotem; Nili Raz; Yechezkel Kashi; Amram Mor
Journal:  Appl Environ Microbiol       Date:  2010-04-02       Impact factor: 4.792

Review 10.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.